Wegovy, every mention
16 scenes · ← back to Wegovy
tap a year for its mentions
every year anyone David Rosenthal 10Ben Gilbert 6
Verbatim, from the transcripts: the passages where Wegovy comes up
Renaissance Technologies (Audio) · Acquired
- ▶ 3:09:56 Ben Gilbert Well, really creator, or a person who led the team that created Liraglutide, which went on to become Semaglutide, which of course is Ozempic, Wegovi, et cetera.
Novo Nordisk (Ozempic) · Acquired
- ▶ 0:37 Ben Gilbert Today's episode is on the company behind these sensational diabetes and weight loss drugs, Ozempic and WeGovi.
- ▶ 2:46 Ben Gilbert The crazy thing is, semeglutide, the molecule in Ozempic and Wegovi, was pioneered back by Novo Nordisk with the first trial in 2008 for type two diabetes treatment.
- ▶ 1:41:23 David Rosenthal That it is, but I'm pretty sure many of you know what that term means, or even if you don't, you've probably heard the marketing names for the current class of those drugs that Novo Nordisk has on the market, which would be Ozempic and…
- ▶ 1:51:36 David Rosenthal Not Ozempic, not Victoza, not Wegavi, something completely different.
- ▶ 2:16:34 David Rosenthal Of course, Ozempic and Wegovy.
- ▶ 2:16:39 David Rosenthal Ozempic is the diabetes marketing product, and Wegovy is the weight loss marketing product.
- ▶ 2:19:13 David Rosenthal So, 2018, Ozempic finally hits the market for diabetes, and then in 2021, Wagavi gets approved for weight loss.
- ▶ 2:19:42 David Rosenthal These drugs still Ozempic and Wagabee could do a lot more revenue than they are doing right now.
- ▶ 2:20:57 David Rosenthal So when Wegevee finally launches in the U.S. in 2021 as the official FDA sanctioned weight loss version of semaglutide, it gets the same number of prescriptions written for it by doctors.
- ▶ 2:21:30 David Rosenthal And then now, Wegge V Supply, fully exhausted.
- ▶ 2:21:33 Ben Gilbert Well, in February of twenty-twenty-one, after the clinical trial finishes on semaglutide for weight loss, so for a week OV to hit the market in the US, the New York Times runs a story and just calls it a game-changer.
- ▶ 2:27:32 Ben Gilbert The price of Ozempic to treat diabetes is north of a thousand dollars, and Wegovy for weight loss is north of 1300 dollars per month before insurance, and this is in the U.S.
- ▶ 2:36:29 David Rosenthal Ozempic and Wegaby will continue to be huge hits.
- ▶ 2:50:30 David Rosenthal When we very first started talking about potentially doing this episode a number of months ago, I thought the same thing you did about Manjaro about Wegovy.
- ▶ 2:53:33 Ben Gilbert We go V.